Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic

Tilray Medical has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group.

G
Adobe Stock By pattersonic

COLOGNE, Germany, April 06, 2023 - PRESS RELEASE - Tilray Brands, Inc., a global cannabis company inspiring and empowering the worldwide community to live their very best life, announced that its medical cannabis division, Tilray Medical, has expanded its European footprint across the Czech Republic through a new export and distribution partnership with Cansativa Group. The new strategic partnership broadens Tilray Medical’s distribution of EU-GMP certified medical cannabis products across pharmacies and hospitals to support medical cannabis patient care.

Denise Faltischek, chief strategy officer and head of international, Tilray Brands, Inc. said, "We are extremely proud to broaden our distribution across the Czech Republic and offer our EU-GMP certified medicinal cannabis products to help support medical cannabis patients in need. Our Tilray Medical team remains dedicated to patient advocacy across our international markets by providing quality medicinal cannabis for commercial, compassionate access, and research purposes."

Tilray Medical is one of the leading providers of EU-GMP certified medicinal cannabis in the world. Today, Tilray Medical offers a comprehensive portfolio of medical cannabis products in over 20 countries that patients may access by consulting their healthcare practitioner.

Page 1 of 644
Next Page